[Part 1]
Do you have cancer or know someone who does? The articles and papers below show that the anti-parasite drugs hydroxychloroquine and ivermectin have significant anti-cancer activity. Consider asking your oncologist about this and perhaps requesting a prescription under "off-label" or under "compassionate use" loopholes. Also consider asking a telemedicine doctor from https://speakwithanmd.com/ about getting hydroxychloroquine or ivermectin for preventive (prophylactic) and/or treatment (therapeutic) use for COVID-19. Combatting cancer, COVID, worms, and other parasites - ivermectin is an all-in-one medical tool!
+++++++++++++++++++++
https://www.cancer.gov/about-cancer/treatment/drugs/off-label
Off-Label Drug Use in Cancer Treatment
About Off-Label Drugs
Drugs can be legally sold in the U.S. only after the U.S. Food and Drug Administration (also known as the FDA) has approved them. Drugs are approved after research shows they are safe and effective for a specific use.
Off-label drug use refers to the practice of prescribing a drug for a different purpose than what the FDA approved. This practice is called “off-label” because the drug is being used in a way not described on its package insert. This insert is known as its “label.”
[Much moar at website]
+++++++++++++++++++++
https://www.cancer.org/treatment/treatments-and-side-effects/clinical-trials/compassionate-drug-use.html
Compassionate Drug Use
What is compassionate drug use?
Compassionate drug use means making a new, unapproved drug available to treat a seriously ill patient when no other treatments are available.
Drugs that are being tested but have not yet been approved by the US Food and Drug Administration (FDA) are called investigational drugs. These drugs are normally available only to people who are taking part in a clinical trial.
Being able to use one of these drugs when you are not in a clinical trial is most commonly referred to as compassionate drug use.
+++++++++++++++++++++
https://jeffreydachmd.com/2016/05/ivermectin-antiparasitic-anticancer-wonder-drug/
The 2015 Nobel Prize in Medicine went for discovery of Ivermectin, an “astonishingly safe” FDA approved anti-helminthic drug.
200 million people take the drug globally for prevention or treatment of parasitic disease.
Dr Sharmeen at the University of Toronto screened a library of 100 drugs for activity against a leukemic cell line, and reported Ivermectin as most promising, inducing leukemic cell death at low micromolar concentrations, while sparing normal cells. Ivermectin was also effective against leukemia mouse xenografts. Ivermectin was patented in 2012 for treating hematological malignancy. Dr Hashimoto reported in 2009, Ivermectin effective against ovarian cancer cell lines (14.)
Dr Alice Melotti studied Ivermectin as an inhibitor of the WNT‐TCF pathway in cancer. Her report was published in 2014 EMBO molecular medicine. Dr Melotti used a transcriptional reporter assay for TCF activity driven by Beta-CATENIN to test a collection of 1,040 drugs and small molecules. Only one agent, Ivermectin, perfectly tracked the gene expression profile induced by blocking the TCF gene, and therefore inhibits the WNT pathway. This has profound significance for anti-cancer stem cell therapy, because blocking the WNT pathway is the key to killing cancer stem cells. (15-16) Blocking the WNT pathway in a breast cancer model killed cancer stem cells.(18) Similarly, blocking the WNT pathway in Mantle cell lymphoma preferentially killed the cancer stem cells.(16)
[Much moar at website]
+++++++++++++++++++++
[Go to Part 2]